Supernus Pharm (SUPN) Posts Q3 Loss of 55c/Share

Supernus Pharm (NASDAQ: SUPN) reported Q3 EPS of ($0.55), $0.07 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Eastgroup Properties (EGP) Tops Q1 EPS by 17c, provides guidance
• KKR Real Estate Finance Trust (KREF) Tops Q1 EPS by 4c